SHAFF ERIC D. (See Remarks) sold 2.2% of their position (259.00 shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0001193125-26-057156
Officer· See Remarks
Since Jan 2019
-260.00
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
723.00 acquired · 983.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+723.00
Price / share
—
Trade value
—
% of position
6.5%
2/15/2026
11.11K→11.84K
Common Stock
Direct
Shares
−259.00
Price / share
$8.47
Trade value
$2.19K
% of position
2.2%
2/15/2026
11.84K→11.58K
Total
Net shares
+464.00
Net value
-$2.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2026 | M · Option Exercise | +723.00 | — | — | 6.5% | 11.11K | 11.84K |
| Common Stock Direct | 2/15/2026 | S · Sale | −259.00 | $8.47 | $2.19K | 2.2% | 11.84K | 11.58K |
| Total | +464.00 | -$2.19K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
391.00 shares
Shares
−391.00
Strike price
Held after
1.56K
Exercisable
—
2/15/2026
Restricted Stock Units
Direct
Converts to
Common Stock
333.00 shares
Shares
−333.00
Strike price
Held after
2.66K
Exercisable
—
2/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock391.00 shares | 2/15/2026 | M · Option Exercise | −391.00 | — | 1.56K | |
| Restricted Stock Units Direct | Common Stock333.00 shares | 2/15/2026 | M · Option Exercise | −333.00 | — | 2.66K |